Insulin resistance and steatosis in humans (Q37386085)

20 August 2017

1 reference

title

Insulin resistance and steatosis in humans (English)

1 reference

20 August 2017

1 reference

1 reference

1 reference

J Capeau

1

1 reference

20 August 2017

1 December 2008

1 reference

20 August 2017

Diabetes and Metabolism

1 reference

20 August 2017

34

1 reference

20 August 2017

6 Pt 2

1 reference

20 August 2017

649-657

1 reference

[Lipodystrophic syndromes: congenital or acquired diseases of adipose tissue]

20 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Critical nodes in signalling pathways: insights into insulin action

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

The double life of Irs.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Disordered lipid metabolism and the pathogenesis of insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Increased Expression and Activity of the Transcription Factor FOXO1 in Nonalcoholic Steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Regulation of plasma triglycerides in insulin resistance and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

SREBP-1c transcription factor and lipid homeostasis: clinical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Dissection of endoplasmic reticulum stress signaling in alcoholic and non-alcoholic liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Etiology of insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Inflammation and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Positive and negative regulation of insulin signaling through IRS-1 phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Obesity, Inflammation, and Insulin Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

TLR4 links innate immunity and fatty acid-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Circulating concentration of adiponectin and its expression in subcutaneous adipose tissue in patients with highly active antiretroviral therapy-associated lipodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Role of mitochondria in non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Dietary fat content modifies liver fat in overweight nondiabetic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Splanchnic lipolysis in human obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Fat in the liver and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Review: The role of insulin resistance in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Liver fat in the metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2808%2974600-7

7 January 2021

10.1016/S1262-3636(08)74600-7

Identifiers

DOI

1 reference

20 August 2017

1 reference

PubMed ID

19195626